Board of Directors

Jeff Jochims
President, Safety Market Division, Thermo Fisher Scientific

Jeff Jochims' responsibilities span Thermo Fisher Scientific’s $4 billion global channel business, branded as "Fisher Scientific". Jeff oversees global strategy development and implementation and facilitates new market development through both organic efforts and acquisition of strategic targets. Recent activities have included substantial investments and growth in India, Ireland, Spain, Norway and throughout additional areas within Europe and Asia. During his career, Jeff has also worked closely with the Fisher Clinical Services business and supported its activities in the area of clinical trial packaging and management and related services.

Paula Brown Stafford
Vice President, Integrated Clinical Services, Quintiles

Paula Brown Stafford joined Quintiles in 1985 as a Biostatistician. She is currently Executive Vice President of Integrated Clinical Services for Quintiles. Her responsibilities comprise a number of global business units generating data from clinical trials, including central laboratories, Phase I research groups, cardiac safety, data management and analysis, and the Center for Statistics. Additionally, she chairs Quintiles Enterprise Data Council.

Robert Beechey
Vice President of Finance and Strategic Planning, Fisher BioPharma Services

Bob Beechey has been the VP of Finance and Strategic Planning for the Fisher BioPharma Services Division of Thermo Fisher Scientific since 2007. Previously, Bob held a variety of senior executive positions during a ten-year career at Eastman Kodak Company. Bob spent ten years with Arthur Andersen including a three-year assignment in the Stuttgart Germany office and as Senior Manager for their New York office. Bob has had a heavy concentration of mergers and acquisition activity during his career in addition to his corporate and operational assignments. Bob received his MBA with Distinction from INSEAD in Fontainebleau, France and his Bachelor of Science in Economics from the Wharton School of University of Pennsylvania.

Patrick M. Durbin
President, Fisher BioPharma Services

Patrick Durbin is President, BioPharma Services, a specialty division of Thermo Fisher Scientific. Patrick joined Thermo Fisher Scientific as General Manager, N. America for Fisher Clinical Services (FCS) in 2006 and was responsible for a suite of high-growth service lines that support the manufacturing, packaging and distribution of drugs, biologics and materials used in clinical trials. Patrick was promoted in 2008 to lead the Fisher Clinical Services business globally. Prior to joining FCS, Patrick had a sixteen year career with Covance (NYSE: CVD), formerly a division of Corning, Inc., where he held a variety of global senior management positions. Patrick holds a Bachelor’s degree in Biology and an M.B.A. in Pharmaceutical Marketing. He has completed the General Management program at Columbia University and the leadership development programs at both Thermo Fisher and Covance.

Ferzaan N. Engineer, Ph.D.
Chief Executive Officer, Quintiles Research

Ferzaan N Engineer, Ph.D., is CEO Quintiles Research (India) Private Limited and Chairman of Quintiles Data Processing Centre (India) Private Limited. He is a member of the Asia-Pacific Management Board of Quintiles responsible for managing the Asia-Pacific geographies. Ferzaan has contributed to establishing and growing the Quintiles organisation in India which currently employs over 1300 people at four locations: Ahmedabad, Bangalore, Mumbai and Delhi. After obtaining his B.Pharm. in 1985 from the LM College of Pharmacy in Ahmedabad, Dr. Engineer completed his Ph.D. in Pharmaceutical Sciences in 1990, from the College of Pharmacy at the University of South Carolina, USA. He has attended management training programs at the Kenan-Flagler Business School (USA) and IIMA (India).

Oppel Greeff, MD
Vice Chairman, Quintiles

Upon joining Quintiles, Dr. Greef served as Medical Director for Quintiles South Africa until January 1999, when he was appointed President of Quintiles Transnational's Africa, India and Australia regions. Latin America was added to his portfolio in 2001. In 2002, Dr. Greeff was appointed Chief Executive Officer of Quintiles' global Early Development and Laboratory Services and President, Global Product Development Services, while retaining his geographic responsibilities.